Literature DB >> 16432533

Gynecomastia in patients with prostate cancer: update on treatment options.

R Autorino1, S Perdonà, M D'Armiento, M De Sio, R Damiano, L Cosentino, G Di Lorenzo.   

Abstract

Non-steroidal antiandrogen monotherapy offers potential quality of life benefits over other treatment modalities in patients with prostate cancer. Nevertheless, gynecomastia and breast pain still represent the most bothersome side effects during this treatment. In this update article, recent advances in the management options for gynecomastia/breast pain caused by hormonal manipulation are reviewed and critically analyzed.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16432533     DOI： 10.1038/sj.pcan.4500859

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN： 1365-7852            Impact factor:   5.554


  4 in total

1.  Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Crystal S Denlinger; Tara Sanft; K Scott Baker; Shrujal Baxi; Gregory Broderick; Wendy Demark-Wahnefried; Debra L Friedman; Mindy Goldman; Melissa Hudson; Nazanin Khakpour; Allison King; Divya Koura; Elizabeth Kvale; Robin M Lally; Terry S Langbaum; Michelle Melisko; Jose G Montoya; Kathi Mooney; Javid J Moslehi; Tracey O'Connor; Linda Overholser; Electra D Paskett; Jeffrey Peppercorn; M Alma Rodriguez; Kathryn J Ruddy; Paula Silverman; Sophia Smith; Karen L Syrjala; Amye Tevaarwerk; Susan G Urba; Mark T Wakabayashi; Phyllis Zee; Deborah A Freedman-Cass; Nicole R McMillian
Journal:  J Natl Compr Canc Netw       Date:  2017-09       Impact factor: 11.908

2.  Prolactin drives estrogen receptor-alpha-dependent ductal expansion and synergizes with transforming growth factor-alpha to induce mammary tumors in males.

Authors:  Lisa M Arendt; Linda A Schuler
Journal:  Am J Pathol       Date:  2007-12-21       Impact factor: 4.307

3.  Peri-areolar double-pedicle technique in the treatment of iatrogenic gynecomastia.

Authors:  Claudio Cannistrà; Yousuf Al-Shaqsi
Journal:  Saudi Med J       Date:  2021-05       Impact factor: 1.422

Review 4.  Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review.

Authors:  Frank Kunath; Bastian Keck; Gerd Antes; Bernd Wullich; Joerg J Meerpohl
Journal:  BMC Med       Date:  2012-08-28       Impact factor: 8.775
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.